Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Amortization of Deferred Charges (2016 - 2018)

Surgery Partners' Amortization of Deferred Charges history spans 5 years, with the latest figure at -$127000.0 for Q1 2018.

  • For Q1 2018, Amortization of Deferred Charges fell 107.2% year-over-year to -$127000.0; the TTM value through Mar 2018 reached $5.6 million, down 26.45%, while the annual FY2016 figure was $7.2 million, 14.94% up from the prior year.
  • Amortization of Deferred Charges for Q1 2018 was -$127000.0 at Surgery Partners, down from $2.0 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $2.0 million in Q2 2017 and bottomed at -$127000.0 in Q1 2018.
  • The 5-year median for Amortization of Deferred Charges is $1.7 million (2015), against an average of $1.5 million.
  • The largest annual shift saw Amortization of Deferred Charges soared 46.8% in 2016 before it crashed 107.2% in 2018.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $1.4 million in 2014, then decreased by 4.0% to $1.3 million in 2015, then soared by 46.8% to $1.9 million in 2016, then grew by 5.51% to $2.0 million in 2017, then tumbled by 106.32% to -$127000.0 in 2018.
  • Per Business Quant, the three most recent readings for SGRY's Amortization of Deferred Charges are -$127000.0 (Q1 2018), $2.0 million (Q2 2017), and $1.8 million (Q1 2017).